Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC

Name: Cadonilimab (AK104) With or Without CT as 2rd Line Treatment for ES-SCLC
License: Public Domain

Second Affiliated Hospital of Zunyi Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

immunotherapy, second-line treatment

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 226253
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.